Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLV.L Regulatory News (BLV)

  • There is currently no data for BLV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Belvoir Lettings Plc

31 Oct 2017 12:23

Killik & Co. LLP - Form 8.3 - Belvoir Lettings Plc

Killik & Co. LLP - Form 8.3 - Belvoir Lettings Plc

PR Newswire

London, October 31

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Killik & Co LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Belvoir Lettings Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 19/10/2017 (Opening Disclosure)
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p ordinary shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:1,611,6424.61%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:1,611,6424.61%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:31/10/2017
Contact name:Adam Schollar
Telephone number:02073370400

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
13th Apr 202212:16 pmRNSReport & Accounts and Notice of AGM
4th Apr 20227:00 amRNSFinal Results
22nd Mar 20227:00 amRNSRetail Investor Presentation
11th Mar 20227:00 amRNSStrategic Acquisition
7th Mar 20222:52 pmRNSHolding(s) in Company
31st Jan 20227:00 amRNSTrading Update - Comfortably Ahead of Expectations
28th Jan 20227:00 amRNSDirectorate Appointment
5th Jan 20227:00 amRNSBoard Changes
2nd Dec 20212:01 pmRNSPrice Monitoring Extension
2nd Dec 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSBelvoir to present at Mello
17th Sep 202112:43 pmRNSDirector Dealing
7th Sep 20217:00 amRNSExercise of Options, Director/PDMR Dealing & TVR
2nd Sep 20217:00 amRNSBelvoir to present at AJ Bell investor webinar
11th Aug 20215:18 pmRNSExercise of Options and Total Voting Rights
3rd Aug 20217:00 amRNSHY Trading Update - Ahead of Expectations
15th Jul 20215:31 pmRNSExercise of Options and Total Voting Rights
13th Jul 20212:07 pmRNSExercise of Options and Total Voting Rights
12th Jul 20217:00 amRNSRetail Investor Webinar
1st Jul 20214:04 pmRNSNew Long-Term Incentive Plan
14th Jun 20213:52 pmRNSResults of General Meeting
10th Jun 20215:01 pmRNSExercise of Options, Director/PDMR Dealing & TVR
2nd Jun 20217:00 amRNSBelvoir to present at Proactive Investor Forum
2nd Jun 20217:00 amRNSAcquisition & Strategic Partnership Extension
28th May 20213:55 pmRNSNotice of General Meeting
27th May 202110:46 amRNSResults of Annual General Meeting
27th May 20219:11 amRNSAGM Notice Update
27th May 20217:00 amRNSAGM Trading Update
30th Apr 20217:00 amRNSHolding(s) in Company
27th Apr 20213:18 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSBelvoir to present at Mello
12th Apr 20217:00 amRNSFinal Results
9th Apr 20217:00 amRNSShares Retail Investor Presentation
1st Apr 20217:00 amRNSEarnings Accretive Acquisition
23rd Mar 20217:00 amRNSRetail Investor Presentation
28th Jan 20217:00 amRNSTrading Update - Ahead of Expectations
15th Jan 20215:57 pmRNSExercise of Options, Director/PDMR Dealing & TVR
12th Jan 20217:00 amRNSContinued Growth of Financial Services
8th Jan 20214:00 pmRNSExercise of Options and Total Voting Rights
2nd Dec 20209:05 amRNSSecond Price Monitoring Extn
2nd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSTrading Update
7th Oct 20207:00 amRNS100th Assisted Acquisition
30th Sep 20207:53 amRNSHolding(s) in Company
23rd Sep 202011:30 amRNSHolding(s) in Company
16th Sep 20207:00 amRNSBelvoir to present at Shares event
15th Sep 20209:56 amRNSHolding(s) in Company
11th Sep 20202:35 pmRNSExercise of Options, Director/PDMR Dealing & TVR
11th Sep 202011:40 amRNSClose of Accelerated Bookbuild
11th Sep 20207:00 amRNSProposed Placing to sell ordinary shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.